Oracle (NYSE:ORCL) Shares Down 7% After Analyst Downgrade

Key Points

• Shares fell about 7% after Citizens Jmp cut its price target from $342 to $285, with Oracle trading as low as $135.25 on volume roughly 55% above average.
• Multiple firms have trimmed targets (e.g., Morgan Stanley to $213) though the sell‑side consensus remains a Moderate Buy with an average price target near $295.72.
• Near‑term headwinds include reports of a large $45–50B AI infrastructure funding plan and related equity/debt offerings, plus significant insider selling and emerging securities‑class action risk, all of which raise dilution and financing concerns.

Oracle Corporation (NYSE:ORCL - Get Free Report) traded down 7% during trading on Thursday after Citizens Jmp lowered their price target on the stock from $342.00 to $285.00. Citizens Jmp currently has a market outperform rating on the stock. Oracle traded as low as $135.25 and last traded at $136.3710. 41,629,849 shares were traded during mid-day trading, an increase of 55% from the average session volume of 26,855,730 shares. The stock had previously closed at $146.67.

ORCL has been the topic of a number of other reports. Morgan Stanley cut their target price on shares of Oracle from $320.00 to $213.00 and set an "equal weight" rating on the stock in a report on Friday, January 23rd. Citigroup restated a "market outperform" rating on shares of Oracle in a research note on Wednesday, December 17th. Robert W. Baird decreased their target price on shares of Oracle from $365.00 to $315.00 and set an "outperform" rating for the company in a research note on Tuesday, November 18th. JMP Securities restated a "market outperform" rating and issued a $342.00 price target on shares of Oracle in a research report on Friday, October 17th. Finally, Wells Fargo & Company started coverage on Oracle in a research report on Wednesday, December 3rd. They set an "overweight" rating and a $280.00 price objective for the company. Three analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $295.72.

Insider Buying and Selling

In other Oracle news, Director Naomi O. Seligman sold 2,223 shares of the company's stock in a transaction dated Tuesday, December 23rd. The shares were sold at an average price of $196.61, for a total value of $437,064.03. Following the transaction, the director directly owned 25,596 shares in the company, valued at approximately $5,032,429.56. This represents a 7.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Douglas A. Kehring sold 35,000 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $194.89, for a total value of $6,821,150.00. Following the transaction, the executive vice president directly owned 33,638 shares in the company, valued at approximately $6,555,709.82. This represents a 50.99% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 62,223 shares of company stock worth $12,136,764. 40.90% of the stock is owned by company insiders.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle won new healthcare AI pilot contracts (Oracle Health Clinical AI Agent selected by multiple Canadian organizations), validating product adoption in a visible vertical. Read More.
• Positive Sentiment: Analysts and commentators still point to a large backlog and rapid cloud/AI revenue growth as fundamental supports for the business, giving long-term buyers reason to hold despite the pullback. Read More.
• Neutral Sentiment: Wall Street is recalibrating price targets: Citizens/JMP cut its target to $285 but kept a market‑outperform view, and other shops (BMO, Scotiabank) trimmed targets while preserving constructive ratings — mixed signals that can stabilize but slow recovery. Read More. • Read More.
• Negative Sentiment: Oracle announced very large AI infrastructure funding plans (reports of a $45–50B capital raise and related equity offerings). Investors fear dilution (equity portion) and rising leverage, pressuring the stock. Read More.
• Negative Sentiment: Company is moving forward with major share/bond issuance programs (reports of a $20B common stock sale and senior notes), intensifying dilution and financing worries. That financing news is a near-term catalyst for selling. Read More.
• Negative Sentiment: Multiple law firms have filed or solicited plaintiffs for securities class actions related to Oracle’s disclosures and financing — legal risk increases uncertainty and can deter buy-side interest. Read More.
• Negative Sentiment: Market narratives highlighting Oracle’s reliance on OpenAI and related commercial concentration have increased scrutiny and selling pressure — commentators argue this risk helped accelerate the recent drop. Read More.
• Negative Sentiment: Reports that banks are shopping loans tied to Oracle’s data-center financing and widespread insider selling headlines add to sentiment weakness and technical pressure. Read More.

Institutional Trading of Oracle

Hedge funds have recently made changes to their positions in the stock. Kampmann Melissa S. raised its stake in Oracle by 0.3% during the third quarter. Kampmann Melissa S. now owns 11,910 shares of the enterprise software provider's stock worth $3,350,000 after acquiring an additional 35 shares during the period. McLean Asset Management Corp lifted its stake in Oracle by 0.7% in the third quarter. McLean Asset Management Corp now owns 5,319 shares of the enterprise software provider's stock valued at $1,551,000 after buying an additional 36 shares during the last quarter. Mine & Arao Wealth Creation & Management LLC. boosted its holdings in shares of Oracle by 0.7% during the third quarter. Mine & Arao Wealth Creation & Management LLC. now owns 5,281 shares of the enterprise software provider's stock valued at $1,485,000 after acquiring an additional 36 shares during the period. Voisard Asset Management Group Inc. grew its position in shares of Oracle by 3.4% during the third quarter. Voisard Asset Management Group Inc. now owns 1,127 shares of the enterprise software provider's stock worth $317,000 after acquiring an additional 37 shares during the last quarter. Finally, Avion Wealth increased its holdings in shares of Oracle by 16.6% in the 3rd quarter. Avion Wealth now owns 260 shares of the enterprise software provider's stock worth $73,000 after acquiring an additional 37 shares during the period. Institutional investors and hedge funds own 42.44% of the company's stock.

Oracle Stock Performance

The company's 50-day moving average is $191.31 and its two-hundred day moving average is $235.52. The stock has a market capitalization of $391.81 billion, a P/E ratio of 25.63, a P/E/G ratio of 1.35 and a beta of 1.64. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The business had revenue of $16.06 billion during the quarter, compared to analyst estimates of $16.19 billion. During the same period in the prior year, the company posted $1.47 EPS. The business's revenue for the quarter was up 14.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 23rd. Investors of record on Friday, January 9th were given a $0.50 dividend. The ex-dividend date was Friday, January 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.5%. Oracle's dividend payout ratio (DPR) is 37.59%.

About Oracle

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.